Cortex – Life Sciences Insights

3/31/2023 9:46:31 AM

New opportunities or playing catch-up? New legislative proposals for clinical trials in the UK

By Nicholas de Lacy-Brown

Introduction Clinical trials regulation is about to get an overhaul in the UK. So promised the Medicines & Healthcare products Regulatory...

3/29/2023 12:38:17 PM

By Greg Bodulovic Nicholas Tyacke Tudor Filaret +1 more...

On 23 March 2023, Australia’s therapeutic goods regulator, the Therapeutic Goods Administration (TGA) published a summary of feedback...

3/28/2023 10:50:34 AM

By Greg Bodulovic Gareth Stokes Nicholas Tyacke +2 more...

Last week, OpenAI officially launched the next iteration of its generative AI-based natural language model, GPT-4, the processing model...

3/24/2023 10:00:10 AM

By Lyndsey Hudson Mary Foord-Weston

In the second of our Cortex series on Inspirational Women in Life Sciences, we are proud to feature DLA Piper’s very own Dr Lyndsey...

3/20/2023 10:17:38 AM

By Marco de Morpurgo Nicola Landolfi

A much-awaited extension of the MDR transition period became effective today with the publication of Regulation (EU) 2023/607 in the...

3/17/2023 2:01:15 PM

By Keo Shaw Bethany Hills Daniel Tobey +1 more...

On March 1, 2023, FDA’s Center for Drug Evaluation and Research (CDER) published a discussion paper on artificial intelligence (AI) in...

3/14/2023 2:15:53 PM

By Nicholas Tyacke Greg Bodulovic Alexandra de Zwart

Due to a complex array of legislation, regulations and codes, advertising therapeutic goods in compliance with Australian law can be a...

3/10/2023 3:14:37 PM

By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski +1 more...

Download a copy of our January monthly briefing, which covers key updates and insights in the following areas: Medicinal productsClinical...

3/8/2023 10:27:54 AM

By Mary Foord-Weston

Beginning on International Women’s Day (IWD), DLA Piper’s Cortex blog is running a series with inspirational guest speakers to celebrate...